IMIGLUCERASE

FDA Drug Profile — Cerezyme

Drug Details

Generic Name
IMIGLUCERASE
Brand Names
Cerezyme
Application Number
BLA020367
Sponsor
Genzyme Corporation
NDC Codes
2
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
IMIGLUCERASE

Indications and Usage

1 INDICATIONS AND USAGE CEREZYME is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adults and pediatric patients. CEREZYME is a hydrolytic lysosomal glucocerebrosidase-specific enzyme indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adults and pediatric patients. ( 1 )